Related Experiment Video
Updated: Aug 26, 2025

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
Published on: September 28, 2022
Implementation of an Opioid Weaning Protocol at a Tertiary Care Children's Hospital
Jenna Ford1, Aaron Harthan1, Jeremy McGarvey1
1OSF HealthCare Children's Hospital of Illinois, Peoria, Illinois.
Insights
Implementing a pharmacist-led opioid weaning protocol and the Withdrawal Assessment Tool-1 significantly reduced opioid wean duration and hospital stays in pediatric patients. This approach offers a standardized method for managing opioid withdrawal in children.
Area of Science:
- Pediatric critical care medicine
- Pharmacology
- Clinical pharmacy
Background:
- Opioid weaning in pediatric patients can be prolonged and complex.
- Standardized protocols are needed to manage opioid withdrawal effectively.
- Pharmacist involvement can optimize medication management.
Purpose of the Study:
- To evaluate a pharmacist-managed opioid weaning regimen combined with an objective opioid withdrawal assessment tool.
- To determine the impact on opioid wean duration, length of hospital stay, and withdrawal episodes.
- To assess the feasibility of implementing this combined approach in pediatric care.
Main Methods:
- Retrospective cohort study of 115 pediatric inpatients from 2012-2020.
- Phased implementation: baseline, pharmacist-led weaning, and addition of the Withdrawal Assessment Tool-1 (WAT-1).
- Data collected on wean duration, hospital length of stay, and opioid withdrawal episodes requiring rescue doses.
Main Results:
- Significant reductions in total wean duration and hospital length of stay were observed from baseline to the intervention phase with WAT-1.
- Episodes of opioid withdrawal requiring rescue medication also decreased significantly.
- No significant differences in patient characteristics were noted between study phases.
Conclusions:
- A pharmacist-managed opioid weaning regimen, enhanced by the WAT-1, significantly shortens opioid wean duration and hospital length of stay in pediatric patients.
- This combined strategy demonstrates potential for widespread adoption and standardization in tertiary care children's hospitals.
- Optimizing opioid withdrawal management can improve patient outcomes and resource utilization.
Objectives:
Evaluate the implementation of a pharmacist-managed opioid weaning regimen and objective opioid withdrawal assessment tool in pediatric patients requiring an opioid wean. We hypothesized that this combination would be associated with a reduction in the wean duration and length of stay and decrease episodes of opioid withdrawal.
Methods:
Retrospective cohort study utilizing pediatric inpatients requiring an inpatient opioid medication wean. The study was conducted in 3 phases from chart review of patients admitted from 2012 to 2020: baseline preintervention (phase 1), pharmacist-managed weaning regimen (phase 2), and addition of an objective assessment tool, the Withdrawal Assessment Tool-1 (phase 3). Data collection included the total wean duration, total duration of hospital admission, and number of episodes of opioid withdrawal.
Results:
The study included 115 patients with 36 patients in phases 1 and 3 and 43 patients in phase 2. Median age ranged from 0.46 to 0.84 years and the majority of children were males. No significant differences in patient characteristics such as age, weight, sex, and previous opioid exposure were found between phases. Length of stay, wean duration, and episodes of withdrawal with need for rescue dose all decreased significantly from phase 1 to phase 3.
Conclusions:
Use of a pharmacist-managed weaning regimen combined with the Withdrawal Assessment Tool-1 tool was associated with significantly shorter methadone weans and overall length of stay. This has implications for wide spread dissemination and standardization of this approach in tertiary care children's hospitals caring for patients after ICU admission.
More Related Videos
07:11Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Kidney Transplant III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care